Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML

Although the landscape for treating acute myeloid leukemia (AML) patients has changed substantially in recent years, the majority of patients will eventually relapse and succumb to their disease. Allogeneic stem cell transplantation provides the best anti-AML treatment strategy, but is only suitable...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixdorf, D., Sponheimer, M., Berghammer, D., Engert, F., Bader, U., Philipp, N., Kazerani, M., Straub, T., Rohrbacher, L., Wange, L., Dapa, S., Atar, D., Seitz, C. M., Brandstetter, K., Linder, A., von Bergwelt, M., Leonhardt, H., Mittelstaet, J., Kaiser, A., Bücklein, V., Subklewe, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244166/
https://www.ncbi.nlm.nih.gov/pubmed/37106163
http://dx.doi.org/10.1038/s41375-023-01905-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244166/
https://www.ncbi.nlm.nih.gov/pubmed/37106163
http://dx.doi.org/10.1038/s41375-023-01905-0

Ejemplares similares